Is the QuantiFERON-TB blood assay a good replacement for the tuberculin skin test in tuberculosis screening? A pilot study at Berkshire Medical Center

American Journal of Clinical Pathology

Volumn 132, Issue 5, 2009, Pages 678-686

  Zhao, Xiangrong ^a   Mazlagic, Damir ^a   Flynn, Ethan A ^a   Hernandez, Helda ^a   Abbott, Charles L ^a  

^a BERKSHIRE MEDICAL CENTER   (United States)

Author keywords

Berkshire Medical Center; Interferon release assay; QuantiFERON TB; Tuberculin skin test; Tuberculosis

Indexed keywords

GAMMA INTERFERON;

ARTICLE; BCG VACCINATION; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; HEALTH CARE PERSONNEL; HOSPITAL; HUMAN; PILOT STUDY; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS; BLOOD; BLOOD EXAMINATION; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; MASS SCREENING; METHODOLOGY; REPRODUCIBILITY;

CROSS-SECTIONAL STUDIES; HEMATOLOGIC TESTS; HUMANS; MASS SCREENING; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS;

EID: 70449711260     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPUHC34NBDGKKL     Document Type: Article

References (22)

1. Joshi R, Reingold AL, Menzies D, et al. Tuberculosis among health-care workers in low- and middle-income countries: a systematic review. PLoS Med. 2006;3:e494. doi:10.1371/journal.pmed.0030494.
2. World Health Organization. WHO Report 2008: Global Tuberculosis Control: Surveillance, Planning, Financing. Geneva, Switzerland: World Health Organization; 2008.
3. Pai M, Gokhale K, Joshi R, et al. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon γ assay with tuberculin skin testing. JAMA. 2005;293:2746-2755. (Pubitemid 40973379)
4. Mazurek GH, Jereb J, Lobue P, et al. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep. 2005;54:49-55.
5. Luetkemeyer AF, Charlebois ED, Flores LL, et al. Comparison of an interferon-γ release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med. 2007;175:737-742. (Pubitemid 46536491)
6. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007;146:340-354. (Pubitemid 351650594)
7. Diel R, Loddenkemper R, Meywald-Walter K, et al. Predictive value of a whole blood IFN-γ assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med. 2008;177:1164-1170. (Pubitemid 351717577)
8. Pai M, Zwerling A, Menzies D. Systematic review: T-cell- based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008;149:177-184.
9. Nahid P, Pai M, Hopewell PC. Advances in the diagnosis and treatment of tuberculosis. Proc Am Thorac Soc. 2006;3:103-110.
10. Nienhaus A, Schablon A, Diel R. Interferon-gamma release assay for the diagnosis of latent TB infection: analysis of discordant results, when compared to the tuberculin skin test. PLoS ONE. 2008;3:e2665. doi:10.1371/journal.pone. 0002665.
11. Mazurek GH, Zajdowicz MJ, Hankinson AL, et al. Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-gamma release assays. Clin Infect Dis. 2007;45:826-836.
12. Menzies D, Tannenbaum TN, FitzGerald JM. Tuberculosis, 10: prevention. CMAJ. 1999;161:717-724.
13. Farhat M, Greenaway C, Pai M, et al. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis. 2006;10:1192-1204. (Pubitemid 44713473)
14. Harada N, Nakajima Y, Higuchi K, et al. Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol. 2006;27:442-448. (Pubitemid 43835524)
15. Pathan AA, Wilkinson KA, Klenerman P, et al. Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis - infected individuals: associations with clinical disease state and effect of treatment. J Immunol. 2001;167:5217-5225. (Pubitemid 33009758)
16. Dosanjh DP, Hinks TS, Innes JA, et al. Improved diagnostic evaluation of suspected tuberculosis. Ann Intern Med. 2008;148:325-336.
17. Bakir M, Millington KA, Soysal A, et al. A. Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact. Ann Intern Med. 2008;149:777-787.
18. Lawn SD, Bangani N, Vogt M, et al. Utility of interferon-γ ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa. BMC Infect Dis. 2007;7:99. doi:10.1186/1471-2334-7- 99.
19. Miranda C, Yen-Lieberman B, Terpeluk P, et al. Reducing the rates of indeterminate results of the QuantiFERON-TB Gold In-Tube test during routine preemployment screening for latent tuberculosis infection among healthcare personnel. Infect Control Hosp Epidemiol. 2009;30:296-298.
20. Choi JC, Shin JW, Kim JY, et al. The effect of previous tuberculin skin test on the follow-up examination of whole-blood interferon-γ assay in the screening for latent tuberculosis infection. Chest. 2008;133:1415-1420.
21. National Institute for Health and Clinical Excellence. Tuberculosis: Clinical Diagnosis and Management of Tuberculosis, and Measures for Its Prevention and Control: Clinical Guideline 33. London, England: National Institute for Clinical Excellence; 2006.
22. Richeldi L, Ewer K, Losi M, et al. Repeated tuberculin testing does not induce false positive ELISPOT results [letter]. Thorax. 2006;61:180. (Pubitemid 43235438)